Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

By Patrick Wingrove and Ahmed Aboulenein (Reuters) -Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press ...

Tobacco kills 8 million people worldwide every year, but imagine if it could be used to make medicine. The idea isn’t unheard ...

“It is by far the most significant development in the plant-made pharmaceuticals arena right now.” Viral vectors have enough going for them that the technique could become a staple for protein ...

A pharmaceutical company rented an oil-free compressed air setup for the planned maintenance of their compressor room.

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

Three of Lilly's new plants will be used to manufacture pharmaceutical raw ingredients, while the fourth will make injectable medicines, the drugmaker said.

The pharmaceutical firm would invest $27 billion to build the four new manufacturing plants in locations that ... and increase exports of medicines made in the U.S.A.," Risk said.